Moreover, the determination of a-MMP-8 levels in PISF has been shown to be useful for screening susceptible sites and patients, differentiating peri-implant sites, and evaluating the progression of bone loss in peri-implantitis [23,24,25,26]. This evidence concerns the gene MMP8 and Peri-Implantitis.